Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccine-Reference-Cited by-同舟云学术

Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccine

Published:2019-05-23 Issue:8 Volume:97 Page:726-739
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

David Shannon C¹^ORCID,Laan Zoe¹,Minhas Vikrant¹,Chen Austen Y¹,Davies Justin²,Hirst Timothy R¹³⁴,McColl Shaun R¹,Alsharifi Mohammed¹³⁴,Paton James C¹³

Affiliation:

1. Research Centre for Infectious Diseases, and Department of Molecular and Biomedical Science School of Biological Sciences University of Adelaide Adelaide SA Australia

2. Australian Nuclear Science and Technology Organisation Lucas Heights NSW Australia

3. GPN Vaccines Pty Ltd Yarralumla ACT Australia

4. Gamma Vaccines Pty Ltd Yarralumla ACT Australia

Funder

Australian Institute of Nuclear Science and Engineering

National Health and Medical Research Council

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12257